Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ventyx Biosciences Q2 EPS $(0.45) Beats $(0.57) Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:06pm
Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.57) by 21.05 percent. This is a 50.55 percent increase over losses of $(0.91) per share from the same period last year.

Posted In: VTYX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist